Y. Wang

Area of research

Pulmonary and Respiratory Medicine · Cancer Research

Research interest

Research focused on Population and Clinical endpoint, with related work in Oncology, non-small cell lung cancer (NSCLC), Chemotherapy. Notable publications include 'MA13.08 CHOICE-01: A Phase 3 Study of Toripalimab Versus Placebo in Combination With First-Line Chemotherapy for Advanced NSCLC', 'P2.13-30 High-Dose Icotinib in Advanced Non-Small Cell Lung Cancer with EGFR 21 L858R Mutation: The Randomized, Open-Label INCREASE Study', and 'OA13 High-dose Icotinib in Advanced NSCLC with EGFR 21 L858R Mutation: A Randomized, Open-Label Phase II Study'.

Looking for a research collaborator?

Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.